Improvement in vision-related function with intravitreal aflibercept: data from phase 3 studies in wet age-related macular degeneration

To evaluate the effect of intravitreal aflibercept injection on visual function in wet age-related macular degeneration (AMD). Prospective, multicenter, double-masked, active-controlled, parallel-group, randomized phase 3 clinical studies (VEGF Trap-Eye: Investigation of Efficacy and Safety in Wet A...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Ophthalmology (Rochester, Minn.) Minn.), 2015-03, Vol.122 (3), p.571-578
Hauptverfasser:	Yuzawa, Mitsuko, Fujita, Kyoko, Wittrup-Jensen, Kim U, Norenberg, Christiane, Zeitz, Oliver, Adachi, Kenji, Wang, Edward C Y, Heier, Jeffrey, Kaiser, Peter, Chong, Victor, Korobelnik, Jean-Francois
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antibodies, Monoclonal, Humanized - therapeutic use Double-Blind Method Female Humans Intravitreal Injections Male Prospective Studies Ranibizumab Receptors, Vascular Endothelial Growth Factor - therapeutic use Recombinant Fusion Proteins - therapeutic use Sickness Impact Profile Surveys and Questionnaires Vascular Endothelial Growth Factor A - antagonists & inhibitors Visual Acuity - physiology Wet Macular Degeneration - drug therapy Wet Macular Degeneration - physiopathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!